number of significant gastrointestinal lesions detected up to 1 month [clinicaltrials_resource:3d33a9c625a7a62103be74a91c166cd9]
Significant gastrointestinal lesions are ulcers, mucosal inflammation, angiodysplasia, and mass.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
number of significant gastrointestinal lesions detected up to 1 month [clinicaltrials_resource:3d33a9c625a7a62103be74a91c166cd9]
Significant gastrointestinal lesions are ulcers, mucosal inflammation, angiodysplasia, and mass.
Bio2RDF identifier
3d33a9c625a7a62103be74a91c166cd9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3d33a9c625a7a62103be74a91c166cd9
measure [clinicaltrials_vocabulary:measure]
number of significant gastrointestinal lesions detected
time frame [clinicaltrials_vocabulary:time-frame]
up to 1 month
description
Significant gastrointestinal l ...... ion, angiodysplasia, and mass.
identifier
clinicaltrials_resource:3d33a9c625a7a62103be74a91c166cd9
title
number of significant gastrointestinal lesions detected up to 1 month
@en
type
label
number of significant gastroin ...... 3a9c625a7a62103be74a91c166cd9]
@en